The global Allergy Diagnostics market size is predicted to grow from US$ 6955 million in 2025 to US$ 13040 million in 2031; it is expected to grow at a CAGR of 11.0% from 2025 to 2031.
Allergic diseases are the most common clinical diseases, mainly referring to IgE antibody-mediated type I immediate allergy. In addition to relying on a detailed and complete understanding of the medical history, physical examination, skin tests (pricks, intradermal tests) and provocation experiments, the clinical diagnosis of its clinical diagnosis is also one of the important components of the diagnosis of allergic diseases.
The Allergy Diagnostics market is experiencing strong growth due to rising allergy prevalence worldwide, driven by factors such as environmental pollution, changing lifestyles, and increasing awareness about allergic conditions. Allergies, ranging from respiratory and skin allergies to food allergies, have become more common, prompting a higher demand for accurate diagnostic tests to identify specific allergens. Additionally, technological advancements in diagnostic methods, including automated testing and improved accuracy of skin and blood tests, have enhanced the reliability of allergy diagnostics, supporting their adoption across hospitals, specialized clinics, and even at-home testing markets.
However, the market faces challenges such as the high costs associated with advanced allergy diagnostics, which can limit access, particularly in lower-income regions where healthcare budgets are constrained. Limited awareness and accessibility of diagnostic services in developing countries further restrict market growth. Additionally, the variability in allergy symptoms and complexity of testing protocols, which may require multiple tests to accurately identify allergens, can add to patient discomfort and costs. These barriers collectively impact the broader adoption and accessibility of allergy diagnostic solutions, despite the rising need for accurate and timely allergy identification.
The global key players of allergy diagnostics include Thermo Fisher Scientific, PerkinElmer, bioMerieux. The global top three players hold a share over 20%. North Americas is the market, has a share over 40%, followed by Europe, with a share about 30%. In terms of product type, services for over 60%, which is the largest segment, while in terms of application, inhaled allergens is the largest segment, with a share of 40%.
LPI (LP Information)' newest research report, the “Allergy Diagnostics Industry Forecast” looks at past sales and reviews total world Allergy Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Allergy Diagnostics sales for 2025 through 2031. With Allergy Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Allergy Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Allergy Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allergy Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Consumables
Instrument
Services
Segmentation by Application:
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
bioMerieux
Hitachi Chemical Diagnostics
PerkinElmer
HAL Allergy Group
Siemens Healthineers
Stallergenes Greer
HOB Biotech Group
Lincoln Diagnostics
MEDIWISS Analytic
Danaher
Hycor Biomedical
Advanced Clinical Lab
WOLWO Pharma
Shenzhen Saier
Dr.Fooke Lab
Omega Diagnostics
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook